-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, G7xk0O/z0xzUVHh6CHsHheWtQwKP5TogaTBDuS0LOTVa2xl7JfcOhwBLazR6ptzi LxvpmkXG4KuRDpE0zXqDwA== 0001371187-11-000003.txt : 20110302 0001371187-11-000003.hdr.sgml : 20110302 20110302152028 ACCESSION NUMBER: 0001371187-11-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20110302 DATE AS OF CHANGE: 20110302 EFFECTIVENESS DATE: 20110302 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IntegenX Inc CENTRAL INDEX KEY: 0001371187 IRS NUMBER: 000000000 STATE OF INCORPORATION: CA FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-156098 FILM NUMBER: 11655947 BUSINESS ADDRESS: STREET 1: 5720 STONERIDGE DRIVE STREET 2: SUITE 300 CITY: PLEASANTON STATE: CA ZIP: 94588 BUSINESS PHONE: 925-701-3400 MAIL ADDRESS: STREET 1: 5720 STONERIDGE DRIVE STREET 2: SUITE 300 CITY: PLEASANTON STATE: CA ZIP: 94588 FORMER COMPANY: FORMER CONFORMED NAME: MICROCHIP BIOTECHNOLOGIES INC DATE OF NAME CHANGE: 20060802 D 1 primary_doc.xml X0704 D LIVE 0001371187 IntegenX Inc 5720 STONERIDGE DRIVE SUITE 300 PLEASANTON CA CALIFORNIA 94588 925-701-3400 CALIFORNIA MICROCHIP BIOTECHNOLOGIES INC Corporation true Stevan Jovanovich 5720 Stoneridge Drive, Suite 300 Pleasanton CA CALIFORNIA 94588 Executive Officer Director James C. Blair c/o 5720 Stoneridge Drive, Suite 300 Pleasanton CA CALIFORNIA 94588 Director Dennis Harris c/o 5720 Stoneridge Drive, Suite 300 Pleasanton CA CALIFORNIA 94588 Director David Barker c/o 5720 Stoneridge Drive, Suite 300 Pleasanton CA CALIFORNIA 94588 Director Andre Marion c/o 5720 Stoneridge Drive, Suite 300 Pleasanton CA CALIFORNIA 94588 Director Mostafa Ronaghi c/o 5720 Stoneridge Drive, Suite 300 Pleasanton CA CALIFORNIA 94588 Director Dong-Su Kim c/o 5720 Stoneridge Drive, Suite 300 Pleasanton CA CALIFORNIA 94588 Director Biotechnology Decline to Disclose 06 false 2011-01-31 false true true Series B extension and an acquisition by Issuer of GenVault Corporation in exchange for Series B stock pursuant to a Stock Exchange Agreement dated January 31, 2011. 0 20623758 20623758 0 Among the total consideration (i) Cash: $10,034,830.66 (ii) Conversion of notes: $5,588,926.37 (iii) Shares of GenVault Preferred Stock: $5,000,001.50 false 14 0 0 0 false IntegenX Inc /s/ Stevan Jovanovich Stevan Jovanovich President and CEO 2011-03-02 -----END PRIVACY-ENHANCED MESSAGE-----